Press Release

Ovia Health Unveils New Fertility and Family Building Benefit

Ovia Health by Labcorp (Ovia) today announced it will offer a first-of-its-kind Fertility and Family Building Benefit, providing companies and health plans a comprehensive and customizable solution to support the diverse family-building journeys of their employees and health plan members. “Compared to existing fertility point solutions that approach fertility health as a single point in time, we designed our Fertility and Family Building…

Pioneer Life Sciences Fund Invests in At-Home Fertility Care Company Béa Fertility    

Pioneer Group has announced an investment in Béa Fertility to further expand the company’s at-home fertility treatment programme. Proceeds will be used to fuel growth in the UK market and achieve FDA clearance ahead of US commercialisation. The Béa Treatment Programme starts with a 5-minute Online Medical Consultation. Once suitability is assessed, the Béa Treatment Programme commences with an at-home Intracervical Insemination…

Texas A&M Health and Philips Expand Their Partnership to Improve Maternal Health with Their Pregnancy+ App

Texas A&M University Health Science Center (Texas A&M Health) and Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, are collaborating to improve health outcomes for mothers, children and families. The collaboration centers on the Pregnancy+ App, which supports parents from the moment they discover they are pregnant through childbirth by offering personalized content, expert- written information, as well as interactive 3D models…

Gynesonics Announces $67M Financing to Expand Commercialization of Its Sonata Procedure Targeting Uterine Fibroids

Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that it has secured an incremental $42.5 million in financing (total of $67.2M inclusive of initial April 2023 financing). The round was led by existing Gynesonics investors Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital; with new…

Signos Raises $20M Series B Funding to Expand Its Metabolic Health and Weight Loss Platform

Signos, a comprehensive metabolic health platform that includes a proprietary AI-engine with a continuous glucose monitor (CGM) to provide real-time data and recommendations for healthy weight management, announced $20 million in Series B funding to respond to the obesity and metabolic health crisis plaguing the US. This new round will allow Signos to expand its core team and platform and conduct additional…